Cipla
Sameer Juneja is an accomplished professional with extensive experience in the pharmaceutical and life sciences sectors, currently serving as the Head of Global Access Business Operations at Cipla since May 2014, where responsibilities include a Chief Operating Officer role aimed at business turnaround. Previous roles at Cipla include heading Supply Chain for Emerging Markets and Europe, and International Business Operations, where Sameer facilitated significant business model transformations. Prior to Cipla, Sameer worked at Accenture Services Pvt. Ltd. as a Senior Principal specializing in management consulting for pharmaceuticals and life sciences, and held positions at Ranbaxy Laboratories, Synovate Business Consulting, Jubilant Organosys, and Citypharmacy Limited. Sameer's educational background includes an MBA from Goa Institute of Management, a B.Pharma from Meerut University, and advanced studies in Venture Capital and Private Equity from Columbia Business School and Imperial College Business School.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.